Meng Xia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Meng Xia has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Susan Murray
Department of Biostatistics
6 shared publications - Nabihah Tayob
Harvard Medical School, Boston, Massachusetts
3 shared publications - Ella A. Kazerooni
University of Michigan Medical Group, Division of Cardiothoracic Radiology, Ann Arbor Michigan
2 shared publications - Kevin R. Flaherty
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and
2 shared publications - Margaret L. Salisbury
Vanderbilt University Medical Center Department of Medicine Nashville, TN
2 shared publications - Bethany Beilue Moore
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, USA
1 shared publication
Latest Publications
- 15 November 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (30) , 5657-5669
Nonparametric group sequential methods for recurrent and terminal events from multiple follow‐up windows
Few methods are currently available for group sequential analysis of recurrent events data subject to a terminal event in the clinical trial setting. This research helps fill this gap by developing a completely nonparametric group sequential monitoring procedure for use with the two‐sample Tayob and Murray statistic. Advantages of the Tayob and Murray statistic include high power to detect treatment differences when there is correlation between recurrent event times or between recurrent and terminal events in an individual. This statistic does not suffer bias from dependent censoring, regardless of the correlation between event times in an individual. This manuscript briefly reviews the Tayob and Murray statistic, develops and describes how to use methods for its group sequential analysis, and through simulation, compares its operating characteristics with those of Cook and Lawless, which is currently in use as the only available nonparametric method for group sequential analysis of recurrent event data. The merits of our proposed approach are most clearly demonstrated when gap times between recurrent events are correlated; when gap times between events are independent, the Cook and Lawless method is difficult to beat. Simulations demonstrate that as correlation between recurrent event times grows, the reduction in power using the Cook and Lawless approach is substantial when compared to our method. Finally, we use our method to analyze recurrent acute exacerbation outcomes from the azithromycin in chronic obstructive pulmonary disease trial.
- 15 November 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (30) , 5657-5669
Nonparametric group sequential methods for recurrent and terminal events from multiple follow‐up windows
Few methods are currently available for group sequential analysis of recurrent events data subject to a terminal event in the clinical trial setting. This research helps fill this gap by developing a completely nonparametric group sequential monitoring procedure for use with the two‐sample Tayob and Murray statistic. Advantages of the Tayob and Murray statistic include high power to detect treatment differences when there is correlation between recurrent event times or between recurrent and terminal events in an individual. This statistic does not suffer bias from dependent censoring, regardless of the correlation between event times in an individual. This manuscript briefly reviews the Tayob and Murray statistic, develops and describes how to use methods for its group sequential analysis, and through simulation, compares its operating characteristics with those of Cook and Lawless, which is currently in use as the only available nonparametric method for group sequential analysis of recurrent event data. The merits of our proposed approach are most clearly demonstrated when gap times between recurrent events are correlated; when gap times between events are independent, the Cook and Lawless method is difficult to beat. Simulations demonstrate that as correlation between recurrent event times grows, the reduction in power using the Cook and Lawless approach is substantial when compared to our method. Finally, we use our method to analyze recurrent acute exacerbation outcomes from the azithromycin in chronic obstructive pulmonary disease trial.
- 30 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 39 (1) , 1-15
Regression analysis of recurrent‐event‐free time from multiple follow‐up windows
This research develops multivariable restricted time models appropriate for analysis of recurrent events data, where data is repurposed into censored longitudinal time‐to‐first‐event outcomes in τ‐length follow‐up windows. We develop two approaches for addressing the censored nature of the outcomes: a pseudo‐observation (PO) approach and a multiple‐imputation (MI) approach. Each of these approaches allows for complete data methods, such as generalized estimating equations, to be used for the analysis of the newly constructed correlated outcomes. Through simulation, this manuscript assesses the performance of the proposed PO and MI methods. Both PO and MI approaches show attractive results with either correlated or independent gap times in an individual. We also demonstrate how to apply the proposed methods in the data from azithromycin in Chronic Obstructive Pulmonary Disease Trial.
- 30 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 39 (1) , 1-15
Regression analysis of recurrent‐event‐free time from multiple follow‐up windows
This research develops multivariable restricted time models appropriate for analysis of recurrent events data, where data is repurposed into censored longitudinal time‐to‐first‐event outcomes in τ‐length follow‐up windows. We develop two approaches for addressing the censored nature of the outcomes: a pseudo‐observation (PO) approach and a multiple‐imputation (MI) approach. Each of these approaches allows for complete data methods, such as generalized estimating equations, to be used for the analysis of the newly constructed correlated outcomes. Through simulation, this manuscript assesses the performance of the proposed PO and MI methods. Both PO and MI approaches show attractive results with either correlated or independent gap times in an individual. We also demonstrate how to apply the proposed methods in the data from azithromycin in Chronic Obstructive Pulmonary Disease Trial.
- 1 July 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (1) , 63-74
First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation
Rationale: “Noninfectious” pulmonary complications are significant causes of morbidity and mortality after allogeneic hematopoietic cell transplant. Early-onset viral reactivations or infections are common after transplant. Whether the first-onset viral infection causes noninfectious pulmonary complications is unknown. Objectives: To determine whether the first-onset viral infection within 100 days after transplant predisposes to development of noninfectious pulmonary complications. Methods: We performed a retrospective review of 738 allogeneic hematopoietic cell transplant patients enrolled from 2005 to 2011. We also established a novel bone marrow transplantation mouse model to test whether herpesviral reactivation after transplant causes organ injury. Measurements and Main Results: First-onset viral infections with human herpesvirus 6 or Epstein-Barr virus within 100 days after transplant increase the risk of developing idiopathic pneumonia syndrome (adjusted hazard ratio [aHR], 5.52; 95% confidence interval [CI], 1.61–18.96; P = 0.007; and aHR, 9.21; 95% CI, 2.63–32.18; P = 0.001, respectively). First infection with human cytomegalovirus increases risk of bronchiolitis obliterans syndrome (aHR, 2.88; 95% CI, 1.50–5.55; P = 0.002) and grade II–IV acute graft-versus-host disease (aHR, 1.59; 95% CI, 1.06–2.39; P = 0.02). Murine roseolovirus, a homolog of human herpesvirus 6, can also be reactivated in the lung and other organs after bone marrow transplantation. Reactivation of murine roseolovirus induced an idiopathic pneumonia syndrome–like phenotype and aggravated acute graft-versus-host disease. Conclusions: First-onset herpesviral infection within 100 days after allogeneic hematopoietic cell transplant increases risk of pulmonary complications. Experimentally reactivating murine roseolovirus causes organ injury similar to phenotypes seen in human transplant recipients.
- 1 July 2019
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 200 (1) , 63-74
First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation
Rationale: “Noninfectious” pulmonary complications are significant causes of morbidity and mortality after allogeneic hematopoietic cell transplant. Early-onset viral reactivations or infections are common after transplant. Whether the first-onset viral infection causes noninfectious pulmonary complications is unknown. Objectives: To determine whether the first-onset viral infection within 100 days after transplant predisposes to development of noninfectious pulmonary complications. Methods: We performed a retrospective review of 738 allogeneic hematopoietic cell transplant patients enrolled from 2005 to 2011. We also established a novel bone marrow transplantation mouse model to test whether herpesviral reactivation after transplant causes organ injury. Measurements and Main Results: First-onset viral infections with human herpesvirus 6 or Epstein-Barr virus within 100 days after transplant increase the risk of developing idiopathic pneumonia syndrome (adjusted hazard ratio [aHR], 5.52; 95% confidence interval [CI], 1.61–18.96; P = 0.007; and aHR, 9.21; 95% CI, 2.63–32.18; P = 0.001, respectively). First infection with human cytomegalovirus increases risk of bronchiolitis obliterans syndrome (aHR, 2.88; 95% CI, 1.50–5.55; P = 0.002) and grade II–IV acute graft-versus-host disease (aHR, 1.59; 95% CI, 1.06–2.39; P = 0.02). Murine roseolovirus, a homolog of human herpesvirus 6, can also be reactivated in the lung and other organs after bone marrow transplantation. Reactivation of murine roseolovirus induced an idiopathic pneumonia syndrome–like phenotype and aggravated acute graft-versus-host disease. Conclusions: First-onset herpesviral infection within 100 days after allogeneic hematopoietic cell transplant increases risk of pulmonary complications. Experimentally reactivating murine roseolovirus causes organ injury similar to phenotypes seen in human transplant recipients.
- 20 November 2018
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 75 (2) , 494-505
Nonparametric Group Sequential Methods for Evaluating Survival Benefit from Multiple Short-Term Follow-up Windows
This article takes a fresh look at group sequential methods applied to two-sample tests of censored survival data and proposes an alternative method of defining and evaluating treatment benefit. Our method re-purposes traditional censored event time data into a sequence of short-term outcomes taken from (potentially overlapping) follow-up windows. A new two-sample restricted means test based on this restructured follow-up data is proposed along with group sequential methods for its use in the clinical trial setting. This method compares favorably with existing methods for group sequential monitoring of time-to-event outcomes, including methods for monitoring the restricted means test and the logrank test. Our method performs particularly well in cases where there is a delayed treatment effect and/or a subset of cured patients. As part of developing group sequential methods for these analyses, we consider asymmetric error spending approaches that differentially limit the chances of stopping incorrectly for perceived efficacy versus perceived harm attributed to the investigational arm of the trial. Recommendations for how to choose proper group sequential stopping boundaries are given, with supporting simulations and an example from the AIDS Clinical Trial Group.
- 20 November 2018
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 75 (2) , 494-505
Nonparametric Group Sequential Methods for Evaluating Survival Benefit from Multiple Short-Term Follow-up Windows
This article takes a fresh look at group sequential methods applied to two-sample tests of censored survival data and proposes an alternative method of defining and evaluating treatment benefit. Our method re-purposes traditional censored event time data into a sequence of short-term outcomes taken from (potentially overlapping) follow-up windows. A new two-sample restricted means test based on this restructured follow-up data is proposed along with group sequential methods for its use in the clinical trial setting. This method compares favorably with existing methods for group sequential monitoring of time-to-event outcomes, including methods for monitoring the restricted means test and the logrank test. Our method performs particularly well in cases where there is a delayed treatment effect and/or a subset of cured patients. As part of developing group sequential methods for these analyses, we consider asymmetric error spending approaches that differentially limit the chances of stopping incorrectly for perceived efficacy versus perceived harm attributed to the investigational arm of the trial. Recommendations for how to choose proper group sequential stopping boundaries are given, with supporting simulations and an example from the AIDS Clinical Trial Group.
- 1 April 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (7) , 921-929
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes
Rationale: Adaptive multiple features method (AMFM) lung texture analysis software recognizes high-resolution computed tomography (HRCT) patterns. Objectives: To evaluate AMFM and visual quantification of HRCT patterns and their relationship with disease progression in idiopathic pulmonary fibrosis. Methods: Patients with idiopathic pulmonary fibrosis in a clinical trial of prednisone, azathioprine, and N-acetylcysteine underwent HRCT at study start and finish. Proportion of lung occupied by ground glass, ground glass–reticular (GGR), honeycombing, emphysema, and normal lung densities were measured by AMFM and three radiologists, documenting baseline disease extent and postbaseline change. Disease progression includes composite mortality, hospitalization, and 10% FVC decline. Measurements and Main Results: Agreement between visual and AMFM measurements was moderate for GGR (Pearson’s correlation r = 0.60, P < 0.0001; mean difference = −0.03 with 95% limits of agreement of −0.19 to 0.14). Baseline extent of GGR was independently associated with disease progression when adjusting for baseline Gender-Age-Physiology stage and smoking status (hazard ratio per 10% visual GGR increase = 1.98, 95% confidence interval [CI] = 1.20–3.28, P = 0.008; and hazard ratio per 10% AMFM GGR increase = 1.36, 95% CI = 1.01–1.84, P = 0.04). Postbaseline visual and AMFM GGR trajectories were correlated with postbaseline FVC trajectory (r = −0.30, 95% CI = −0.46 to −0.11, P = 0.002; and r = −0.25, 95% CI = −0.42 to −0.06, P = 0.01, respectively). Conclusions: More extensive baseline visual and AMFM fibrosis (as measured by GGR densities) is independently associated with elevated hazard for disease progression. Postbaseline change in AMFM-measured and visually measured GGR densities are modestly correlated with change in FVC. AMFM-measured fibrosis is an automated adjunct to existing prognostic markers and may allow for study enrichment with subjects at increased disease progression risk.
- 1 April 2017
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (7) , 921-929
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes
Rationale: Adaptive multiple features method (AMFM) lung texture analysis software recognizes high-resolution computed tomography (HRCT) patterns. Objectives: To evaluate AMFM and visual quantification of HRCT patterns and their relationship with disease progression in idiopathic pulmonary fibrosis. Methods: Patients with idiopathic pulmonary fibrosis in a clinical trial of prednisone, azathioprine, and N-acetylcysteine underwent HRCT at study start and finish. Proportion of lung occupied by ground glass, ground glass–reticular (GGR), honeycombing, emphysema, and normal lung densities were measured by AMFM and three radiologists, documenting baseline disease extent and postbaseline change. Disease progression includes composite mortality, hospitalization, and 10% FVC decline. Measurements and Main Results: Agreement between visual and AMFM measurements was moderate for GGR (Pearson’s correlation r = 0.60, P < 0.0001; mean difference = −0.03 with 95% limits of agreement of −0.19 to 0.14). Baseline extent of GGR was independently associated with disease progression when adjusting for baseline Gender-Age-Physiology stage and smoking status (hazard ratio per 10% visual GGR increase = 1.98, 95% confidence interval [CI] = 1.20–3.28, P = 0.008; and hazard ratio per 10% AMFM GGR increase = 1.36, 95% CI = 1.01–1.84, P = 0.04). Postbaseline visual and AMFM GGR trajectories were correlated with postbaseline FVC trajectory (r = −0.30, 95% CI = −0.46 to −0.11, P = 0.002; and r = −0.25, 95% CI = −0.42 to −0.06, P = 0.01, respectively). Conclusions: More extensive baseline visual and AMFM fibrosis (as measured by GGR densities) is independently associated with elevated hazard for disease progression. Postbaseline change in AMFM-measured and visually measured GGR densities are modestly correlated with change in FVC. AMFM-measured fibrosis is an automated adjunct to existing prognostic markers and may allow for study enrichment with subjects at increased disease progression risk.
- 1 September 2016
- Published by Elsevier in Respiratory Medicine
- Vol. 118, 88-95
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling
- 1 September 2016
- Published by Elsevier in Respiratory Medicine
- Vol. 118, 88-95
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling